Double‐blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics

Acta Psychiatrica Scandinavica

Volumn 57, Issue 5, 1978, Pages 436-446

  Frangos, H ^a   Zissis, N P ^a   Leontopoulos, I ^a   Diamantas, N ^a   Tsitouridis, S ^a   Gavriil, I ^a   Tsolis, K ^a  

^a State Hospital for Mental Diseases ^*  (Greece)

Author keywords

chronic schizophrenics; fluphenazine decanoate; Fluspirilene; long acting neuroleptics

Indexed keywords

FLUPHENAZINE DECANOATE; FLUSPIRILENE;

ADVERSE DRUG REACTION; CONSTIPATION; DRUG COMPARISON; DRUG THERAPY; EJACULATION; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; INSOMNIA; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PARKINSONISM; SCHIZOPHRENIA; SOMNOLENCE; THERAPY; TINNITUS; TREMOR; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

ADULT; CLINICAL TRIALS; DOUBLE-BLIND METHOD; DRUG EVALUATION; FEMALE; FLUPHENAZINE; FLUSPIRILENE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE, SECONDARY; SCHIZOPHRENIA; SLEEP DISORDERS; SPIRO COMPOUNDS; TREMOR;

EID: 0018104264     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1978.tb06912.x     Document Type: Article

References (25)

1. Das Depotneurolepticum Fluspirilene. Klinische Prüfung im offenen Versuch und als Doppelblindstudie im Vergleich zu Fluphenazin‐Decanoat
2. Klinische Prüfung von fünf Depotneuroleptika
3. Fluspirilene, a new long‐acting injectable neuroleptic
4. Fluspirilene in the treatment of chronic schizophrenic patients
5. Clinical observations on the use of long‐acting phenothiazines (Fluphenazine enanthate) in chronic schizophrenics
6. Clinical experience with fluphenazine decanoate in the treatment of patients with long‐standing schizophrenia
7. Fluspirilene, a long‐acting injectable neuroleptic
8. Fluspirilene in schizophrenia
9. Overview: Maintenance therapy in psychiatry: I
10. Organic therapies
11. The depot compounds Moditen (fluphenazine) and Imap (fluspirilene) in clinical practice
12. The long‐acting phenothiazines
13. Klinische Prüfung eines neuen Langzeitneuroleptikums (Fluspirilene) unter besonderer Berücksichtigung der neuroleptischen Schwelle
14. NOSIE‐30: A treatment sensitive ward behavior scale
15. The pharmacology of fluspirilene (R 6218), a potent long‐acting injectable neuroleptic drug
16. Three years experience with fluphenazine de‐canoate
17. A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes
18. The Brief Psychiatric Rating Scale
19. Clinical evaluation of fluspirilene as a maintenance therapy in chronic schizophrenic patients
20. Fluspirilene in the treatment of chronic schizophrenic outpatients
21. Clinical evaluation of Fluspirilene (R 6218)
22. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long‐acting injectable neuroleptic, in chronic psychotic patients
23. Erfahrungen mit Depotneuroleptika
24. A controlled study of fluspirilene in chronic schizophrenia
25. A comparative double‐blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia